Aspirin for Primary Prevention — Time to Rethink Our Approach [making the case for a precision medicine approach using platelet phenotype]
Only 10% of companies are are truly resilient against supply chain disruptions – an alarming 80% are not
Could we be on the cusp of ending cancer as we know it? the health strategist institute for continuous health transformationand digital health Joaquim Cardoso MScSenior Advisor for continous health transformationand Read More » 6 de janeiro de 2023